Nature Communications (Aug 2020)

Targeted gene correction of human hematopoietic stem cells for the treatment of Wiskott - Aldrich Syndrome

  • Rajeev Rai,
  • Marianna Romito,
  • Elizabeth Rivers,
  • Giandomenico Turchiano,
  • Georges Blattner,
  • Winston Vetharoy,
  • Dariusz Ladon,
  • Geoffroy Andrieux,
  • Fang Zhang,
  • Marta Zinicola,
  • Diego Leon-Rico,
  • Giorgia Santilli,
  • Adrian J. Thrasher,
  • Alessia Cavazza

DOI
https://doi.org/10.1038/s41467-020-17626-2
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 15

Abstract

Read online

In recent years, hematopoietic stem cells gene editing has emerged as a promising tool to treat blood disorders. Here the authors develop a CRISPR/Cas9-based genome editing strategy that allows the precise correction of Wiskott-Aldrich Syndrome in vitro and in vivo with high efficiency.